DUBLIN--(BUSINESS WIRE)--"The Next Generation Sequencing (NGS) Markets in Japan" report has been added to ResearchAndMarkets.com's offering.
This report analyses the market trends influencing various NGS market segments in Japan. It also analyses the global market trends, which have a significant impact in Japan's NGS market. It covers a detailed analysis of the impact of COVID-19 in each market segment.
This is an updated version of the study conducted in 2019. The estimations and forecasts in the original version have been revisited for accommodating the impact of COVID-19, which has affected all the sub-segments across the NGS markets in Japan. The base year of the study is maintained as 2019 since the pandemic situation is still evolving and impact is uncertain to a large extent. The original estimates for each market segment have been revised for 2020 and beyond in this updated version. Response to COVID-19 by each leading market player in Japan has also been evaluated in detail.
This report segments Japan's NGS market with respect to methods, applications, and product as well as service types. The drivers and restraints of segments are evaluated for estimating market size, forecast and COVID-19 impact. The profiles of leading players in the global, as well as Japanese markets, are studied in detail along with their response to the pandemic and impact on their NGS revenues in 2020.
The report also includes a detailed analysis of the regulatory as well as the reimbursement landscapes in Japan that play a major role in shaping the NGS market, particularly related to the clinical diagnostics end-use segments. The report has a total of 310 pages, which includes more than 50 tables.
Key Topics Covered:
Executive Summary
- Summary Table: The NGS Market Size and Forecast in Japan (USD, Million)
- Impact of COVID-19 Pandemic
Market Overview
- NGS Workflow
- NGS Market Trends
- Market Restraints
- Health Insurance Landscape in Japan
- Regulatory Landscape Promoting NGS in Japan
- The NGS Market Landscape in Japan
- NGS Market in Japan and Impact of COVID-19 Pandemic
NGS Markets in Japan by Methods
- Targeted Genome Sequencing and Resequencing
- Whole Genome Sequencing (WGS)
- Whole Exome Sequencing (WES)
- RNA-Seq
- Other NGS Methods
NGS Markets in Japan by Products and Services
- Instruments
- Consumables and Accessories
- Bioinformatics Tools for NGS
- NGS Market Size and Growth Trends in Japan by Products and Services
NGS Markets in Japan by Application Segments
- Clinical Diagnostics
- Direct-to-Consumer (DTC) Genetic Testing
- Research Applications
Company Profiles
- 10x Genomics Inc
- Agilent Technologies
- BGI Group
- Eurofins Scientific
- F. Hoffman-La Roche Ltd
- Foundation Medicine, Inc.
- GeneQuest Co., Ltd
- Genesis Healthcare Co., Japan
- Genewiz (Japan Genewith Co., Ltd)
- Illumina
- Macrogen, Inc
- Oxford Nanopore Technologies
- Pacific Biosciences
- Perkin Elmer, Inc
- Qiagen N. V.
- Riken Genesis Co., Ltd
- Sysmex Corporation
- Takara Bio Inc
- Thermo Fisher Scientific
For more information about this report visit https://www.researchandmarkets.com/r/vw7xxb
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
